SPANU, DARIO
 Distribuzione geografica
Continente #
EU - Europa 12.597
NA - Nord America 759
AS - Asia 530
SA - Sud America 95
AF - Africa 16
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 14.000
Nazione #
IT - Italia 12.312
US - Stati Uniti d'America 729
SG - Singapore 206
CN - Cina 187
SE - Svezia 77
BR - Brasile 75
DE - Germania 49
VN - Vietnam 37
FI - Finlandia 29
GB - Regno Unito 27
FR - Francia 26
IN - India 25
CA - Canada 19
HK - Hong Kong 17
NL - Olanda 16
KR - Corea 14
PL - Polonia 12
AT - Austria 11
MX - Messico 10
IE - Irlanda 9
BE - Belgio 7
ES - Italia 7
EC - Ecuador 6
IR - Iran 6
VE - Venezuela 5
ZA - Sudafrica 5
AR - Argentina 4
IQ - Iraq 4
JP - Giappone 4
TH - Thailandia 4
TR - Turchia 4
BD - Bangladesh 3
GR - Grecia 3
PH - Filippine 3
AE - Emirati Arabi Uniti 2
AU - Australia 2
DZ - Algeria 2
GA - Gabon 2
ID - Indonesia 2
IL - Israele 2
KG - Kirghizistan 2
PE - Perù 2
PK - Pakistan 2
PT - Portogallo 2
AL - Albania 1
AO - Angola 1
AZ - Azerbaigian 1
BH - Bahrain 1
BJ - Benin 1
CO - Colombia 1
CZ - Repubblica Ceca 1
HR - Croazia 1
KE - Kenya 1
KH - Cambogia 1
KZ - Kazakistan 1
LT - Lituania 1
LU - Lussemburgo 1
MA - Marocco 1
MK - Macedonia 1
NG - Nigeria 1
NO - Norvegia 1
PY - Paraguay 1
RS - Serbia 1
RU - Federazione Russa 1
SA - Arabia Saudita 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
UZ - Uzbekistan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 14.000
Città #
Cagliari 11.608
Uta 605
Ashburn 143
Singapore 105
Dallas 78
Boardman 51
Chandler 45
Nyköping 41
Beijing 36
Los Angeles 34
Fairfield 33
New York 28
Rome 25
Hefei 20
The Dalles 19
Helsinki 18
Munich 18
Santa Clara 18
Seattle 16
Shanghai 16
Ho Chi Minh City 15
Hong Kong 14
Seoul 14
Amsterdam 12
Houston 12
Pune 11
Düsseldorf 10
Guangzhou 10
Shenzhen 10
Boston 9
San Diego 9
Warsaw 9
Nuremberg 8
Redondo Beach 8
Wilmington 8
Buffalo 7
Dublin 7
Woodbridge 7
Cambridge 6
Frankfurt am Main 6
Hanoi 6
Montreal 6
Stockholm 6
Turku 6
Vienna 6
Brooklyn 5
Lappeenranta 5
London 5
Menlo Park 5
Mexico City 5
Milan 5
São Paulo 5
Toronto 5
Zhengzhou 5
Bexley 4
Chicago 4
Dong Ket 4
Haiphong 4
La Maddalena 4
Orem 4
Paris 4
Rio de Janeiro 4
Roubaix 4
Selargius 4
Brussels 3
Buenos Aires 3
Denver 3
Johannesburg 3
Manila 3
Peristeri 3
Sassari 3
Wuhan 3
Baghdad 2
Bishkek 2
Calgary 2
Campinas 2
Caracas 2
Charlotte 2
Chennai 2
Clifton 2
Council Bluffs 2
Delhi 2
Don Mueang 2
Enna 2
Fortaleza 2
Godo 2
Islington 2
Istanbul 2
Jinhua 2
Karachi 2
Leuven 2
Libreville 2
Livorno 2
Molenbeek-Saint-Jean 2
Montenegro 2
Nakano 2
Naples 2
Pisa 2
Piscataway 2
Poplar 2
Totale 13.344
Nome #
Molecular-biology-driven treatment for metastatic colorectal cancer 2.716
Hepatocellular carcinoma and microbiota: Implications for clinical management and treatment 1.307
Molecular-driven treatment for biliary tract cancer: the promising turning point 1.183
How to improve metastatic pancreatic ductal adenocarcinoma patients' selection: Between clinical trials and the real-world 1.136
CDX-2 expression correlates with clinical outcomes in MSI-H metastatic colorectal cancer patients receiving immune checkpoint inhibitors 1.005
Neoadjuvant chemo-radiotherapy response in patients affected by mismatch repair deficient (dMMR) locally advanced rectal cancer 945
Liquid Biopsy-Driven Cetuximab Rechallenge Strategy in Molecularly Selected Metastatic Colorectal Cancer Patients 903
Introducing immunotherapy for advanced hepatocellular carcinoma patients: Too early or too fast? 899
Uncovering key targets of success for immunotherapy in pancreatic cancer 679
Circulating tumour DNA in gastrointestinal cancer in clinical practice: Just a dream or maybe not? 668
BRCA-mutant pancreatic ductal adenocarcinoma 583
Prediction of Response to Anti-Angiogenic Treatment for Advanced Colorectal Cancer Patients: From Biological Factors to Functional Imaging 529
Influence of antidiabetic drugs on glucose metabolism and immune response in patients with metastatic pancreatic ductal adenocarcinoma receiving gemcitabine plus nab-paclitaxel as first-line treatment 513
Role of neutrophil-to-lymphocyte ratio (NLR) in the outcome of NSCLC EGFR mutated 291
Mismatch repair proteins (MMR) expression as predictive factor in locally advanced rectal cancer 174
Thyroid dysfunction and immune checkpoint inhibitors: Effect on survival in elderly patients 151
Early taxane exposure and neurotoxicity in breast cancer patients 148
Clinical characteristics and outcomes in patients with early-onset locally advanced rectal cancer 68
The interconnection between cellular metabolism and lymphocyte activation as a prognostic factor in patients affected by metastatic pancreatic ductal adenocarcinoma treated with gemcitabine and nab-paclitaxel as first line 58
Lymphocyte to monocyte ratio in metastatic pancreatic ductal adenocarcinoma as a prognostic factor and its potential role in identifying a subset of patients with a favorable response to therapy 55
The correlation between L1CAM expression and outcomes in patients with metastatic colorectal cancer treated with first-line chemotherapy 50
Totale 14.061
Categoria #
all - tutte 20.994
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.994


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021431 0 0 0 0 0 120 40 64 35 70 49 53
2021/2022892 53 48 3 25 40 78 38 73 63 79 143 249
2022/20232.515 188 345 306 175 170 191 126 211 186 306 186 125
2023/20242.107 94 62 70 114 172 353 344 148 113 150 250 237
2024/20256.641 1.978 2.253 558 560 293 431 251 32 64 77 45 99
2025/2026947 178 151 150 184 157 127 0 0 0 0 0 0
Totale 14.061